SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Takeda reports positive interim results of Moderna trials in Japan

05/10/2021 02:22
Takeda reports positive interim results of Moderna trials in Japan

- Japanese drugmaker Takeda Pharmaceutical Co 4502.T, which is importing Moderna Inc MRNA.O's COVID-19 vaccine into Japan, said interim results of clinical trials ahead of domestic regulatory approvals have been positive.

"The vaccine candidate was generally well-tolerated with no significant safety concerns reported," Takeda said in a statement.


(Reporting by Rocky Swift and Ritsuko Ando in Tokyo; Editing by Kim Coghill)

(([email protected];))